The hope is that renal denervation will solve not only hypertension-related complications but also the various problems associated with antihypertensive drugs that have a negative impact on quality of ...
The US Food and Drug Administration (FDA) has approved the Paradise Ultrasound Renal Denervation system for the treatment of hypertension, Recor Medical Inc and parent company Otsuka Medical Devices ...
A radiofrequency-based renal denervation system for uncontrolled hypertension got a cool reception from FDA advisors who nevertheless left the door open for regulatory approval. On Wednesday, the ...
Credit: Recor Medical. The approval was based on data from the RADIANCE II trial which included patient with mild to moderate hypertension who were adequately controlled with medications. The Food and ...
Advisors on the US Food and Drug Administration’s Circulatory System Devices Panel voted today in support of the premarket approval (PMA) application for the Paradise Ultrasound Renal Denervation ...
The US Food and Drug Administration (FDA) has approved Medtronic's Symplicity Spyral renal denervation system for the treatment of hypertension, the company has announced. The Symplicity Spyral system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results